Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 21


The inhibition of N-glycosylation of glycoprotein 130 molecule abolishes STAT3 activation by IL-6 family cytokines in cultured cardiac myocytes.

Matsuo R, Morihara H, Mohri T, Murasawa S, Takewaki K, Nakayama H, Maeda M, Fujio Y.

PLoS One. 2014 Oct 23;9(10):e111097. doi: 10.1371/journal.pone.0111097. eCollection 2014. Erratum in: PLoS One. 2015;10(3):e0122930.


Stüve-Wiedemann syndrome: LIFR and associated cytokines in clinical course and etiology.

Mikelonis D, Jorcyk CL, Tawara K, Oxford JT.

Orphanet J Rare Dis. 2014 Mar 12;9:34. doi: 10.1186/1750-1172-9-34. Review.


JAK-STAT signaling and myocardial glucose metabolism.

Frias MA, Montessuit C.

JAKSTAT. 2013 Oct 1;2(4):e26458. doi: 10.4161/jkst.26458. Epub 2013 Sep 27. Review.


JAK-STAT: Getting to the heart of the matter.

Barry SP.

JAKSTAT. 2012 Apr 1;1(2):90-1. doi: 10.4161/jkst.20939. No abstract available.


Conserved regulation of the Jak/STAT pathway by the endosomal protein asrij maintains stem cell potency.

Sinha A, Khadilkar RJ, S VK, Roychowdhury Sinha A, Inamdar MS.

Cell Rep. 2013 Aug 29;4(4):649-58. doi: 10.1016/j.celrep.2013.07.029. Epub 2013 Aug 22.


Cardiotrophin-1 induces matrix metalloproteinase-1 in human aortic endothelial cells.

Tokito A, Jougasaki M, Ichiki T, Hamasaki S.

PLoS One. 2013 Jul 23;8(7):e68801. doi: 10.1371/journal.pone.0068801. Print 2013.


LIF and the heart: just another brick in the wall?

Zouein FA, Kurdi M, Booz GW.

Eur Cytokine Netw. 2013 Mar;24(1):11-9. doi: 10.1684/ecn.2013.0335. Review.


α₁A-adrenergic receptors regulate cardiac hypertrophy in vivo through interleukin-6 secretion.

Papay RS, Shi T, Piascik MT, Naga Prasad SV, Perez DM.

Mol Pharmacol. 2013 May;83(5):939-48. doi: 10.1124/mol.112.084483. Epub 2013 Feb 12.


The potential role of aerobic exercise to modulate cardiotoxicity of molecularly targeted cancer therapeutics.

Scott JM, Lakoski S, Mackey JR, Douglas PS, Haykowsky MJ, Jones LW.

Oncologist. 2013;18(2):221-31. doi: 10.1634/theoncologist.2012-0226. Epub 2013 Jan 18. Review.


Leptin-induced cardioprotection involves JAK/STAT signaling that may be linked to the mitochondrial permeability transition pore.

Smith CC, Dixon RA, Wynne AM, Theodorou L, Ong SG, Subrayan S, Davidson SM, Hausenloy DJ, Yellon DM.

Am J Physiol Heart Circ Physiol. 2010 Oct;299(4):H1265-70. doi: 10.1152/ajpheart.00092.2010. Epub 2010 Jul 23.


The chemokine SDF-1/CXCL12 regulates the migration of melanocyte progenitors in mouse hair follicles.

Belmadani A, Jung H, Ren D, Miller RJ.

Differentiation. 2009 Apr;77(4):395-411. doi: 10.1016/j.diff.2008.10.015. Epub 2008 Dec 25.


Role of gp130-mediated signalling pathways in the heart and its impact on potential therapeutic aspects.

Fischer P, Hilfiker-Kleiner D.

Br J Pharmacol. 2008 Mar;153 Suppl 1:S414-27. doi: 10.1038/bjp.2008.1. Epub 2008 Feb 4. Review.


The lack of cardiotrophin-1 alters expression of interleukin-6 and leukemia inhibitory factor mRNA but does not impair cardiac injury response.

Gritman K, Van Winkle DM, Lorentz CU, Pennica D, Habecker BA.

Cytokine. 2006 Oct;36(1-2):9-16. Epub 2006 Dec 5.


Cardioprotective stress response in the human fetal heart.

Coles JG, Boscarino C, Takahashi M, Grant D, Chang A, Ritter J, Dai X, Du C, Musso G, Yamabi H, Goncalves J, Kumar AS, Woodgett J, Lu H, Hannigan G.

J Thorac Cardiovasc Surg. 2005 May;129(5):1128-36.


An essential role of the JAK-STAT pathway in ischemic preconditioning.

Xuan YT, Guo Y, Han H, Zhu Y, Bolli R.

Proc Natl Acad Sci U S A. 2001 Jul 31;98(16):9050-5.


Activated MEK5 induces serial assembly of sarcomeres and eccentric cardiac hypertrophy.

Nicol RL, Frey N, Pearson G, Cobb M, Richardson J, Olson EN.

EMBO J. 2001 Jun 1;20(11):2757-67.


Myocardial protection from ischemia/reperfusion injury by endogenous and exogenous HGF.

Nakamura T, Mizuno S, Matsumoto K, Sawa Y, Matsuda H, Nakamura T.

J Clin Invest. 2000 Dec;106(12):1511-9.


Signal transducer and activator of transcription 3 in the heart transduces not only a hypertrophic signal but a protective signal against doxorubicin-induced cardiomyopathy.

Kunisada K, Negoro S, Tone E, Funamoto M, Osugi T, Yamada S, Okabe M, Kishimoto T, Yamauchi-Takihara K.

Proc Natl Acad Sci U S A. 2000 Jan 4;97(1):315-9.

Supplemental Content

Support Center